Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors | bioRxiv
Precision Medicine in Lung Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes | IntechOpen
IKKα Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization - ScienceDirect
PDF) Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis
Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung Cancer | SpringerLink
Cancers | Free Full-Text | Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy
Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer | BMC Cancer | Full Text
EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling | Cell Death & Disease
Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells | Scientific Reports
Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR - Ariyasu - 2021 - Cancer Science - Wiley Online Library
Frontiers | Case Report: Recombinant Human Endostatin Plus Chemotherapy for Epidermal Growth Factor Receptor-Negative Miliary Lung Adenocarcinoma
Proteomic and Phosphoproteomic Analyses Reveal the Oncogenic Role of PTK7-NDRG1 Axis in Non-small-cell Lung Cancer Cell Resistance to AZD9291 | ACS Chemical Biology
IKKα Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization - ScienceDirect
SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer | Nature Communications
Immunological analysis of 98 lung adenocarcinomas by targeted gene... | Download Scientific Diagram
Clinical Utility of Targeted Sequencing in Lung Cancer: Experience From an Autonomous Swedish Health Care Center
Novel serum biomarkers for lung cancer early diagnosis and clinical outcome
Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells - ScienceDirect
Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer | Molecular Medicine | Full Text
Molecular characterization of non-small cell lung cancer tumors in Latin American patients from Brazil, Chile and Peru uncovers novel potentially driver mutations | medRxiv
Frontiers | Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I–III Non-small Cell Lung Cancer Patients
Lung Cancer | Basicmedical Key
Prognosis of Different Types of Non-Small Cell Lung Cancer Progression: Current State and Perspectives | Cell Physiol Biochem
IJMS | Free Full-Text | The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
